TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33060555

Group type: EXPERIMENTAL
Intervention: Regular scheduled ibuprofen (10 mg/kg per dose, maximum 600 mg every 6 hours)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Pro re nata (PRN) ibuprofen
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Regular scheduled ibuprofen
Number of subjects: 99
Study: 34456194

Group type: EXPERIMENTAL
Intervention: ACTH administration (3 times daily for 7 days)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (n = 4)
Number of subjects: 9
Study: 33560444

Group type: EXPERIMENTAL
Intervention: Vortioxetine
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 121
Study: 32632489

Group type: EXPERIMENTAL
Intervention: WI plus L-TAP
Number of subjects: 102

Group type: COMPARATOR
Intervention: WI
Number of subjects: 102
Study: 32651140

Group type: EXPERIMENTAL
Intervention: Ligament flavum preservation technique
Number of subjects: 251

Group type: COMPARATOR
Intervention: Conventional procedures
Number of subjects: 251
Study: 32991232

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation group (CR) with standard medical treatments and exercise-based cardiac rehabilitation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group with standard medical treatments without exercise
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation group (CR)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study: 33129628

Group type: EXPERIMENTAL
Intervention: Dyadic intervention to improve communication (4 weekly sessions)
Number of subjects: 64
Study: 35742692

Group type: EXPERIMENTAL
Intervention: USD 0.40 incentive for every USD 1.00 spent
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: USD 2 incentive for every USD 1.00 spent (2:1)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Incentive program at the highest level (2:1)
Number of subjects: 77
Study: 33035598

Group type: EXPERIMENTAL
Intervention: Acarbose
Number of subjects: 6000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6000
Study: 37258803

Group type: EXPERIMENTAL
Intervention: Dapagliflozin (10 mg) + Sitagliptin (100 mg) + Metformin (1000 mg) ER
Number of subjects: 415

Group type: COMPARATOR
Intervention: Sitagliptin (100 mg) + Metformin (1000 mg) SR
Number of subjects: 415

Group type: COMPARATOR
Intervention: Dapagliflozin (10 mg) + Metformin (1000 mg) ER
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Dapagliflozin + Sitagliptin + Metformin ER
Number of subjects: 415
Study: 34235909

Group type: EXPERIMENTAL
Intervention: InGaAsP and Er,Cr:YSGG laser adjunctive to subgingival debridement
Number of subjects: 42

Group type: COMPARATOR
Intervention: Subgingival debridement alone
Number of subjects: 42
Study: 32338946

Group type: EXPERIMENTAL
Intervention: Virtual Reality Exposure Therapy (VRE)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure Therapy (PE)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Waitlist Control (WL)
Number of subjects: 90
Study: 36103260

Group type: EXPERIMENTAL
Intervention: Levothyroxine 50mcg daily
Number of subjects: 940

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 940

Group type: EXPERIMENTAL
Intervention: Treated SCH/OH
Number of subjects: 940

Group type: COMPARATOR
Intervention: Euthyroid women
Number of subjects: 940

Group type: COMPARATOR
Intervention: Euthyroid groups
Number of subjects: 940
Study: 34243940

Group type: EXPERIMENTAL
Intervention: EEG-guided anaesthesia
Number of subjects: 1232

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1232
Study: 32552691

Group type: EXPERIMENTAL
Intervention: Modified-ramped position
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ramped position
Number of subjects: 60
Study: 33827424

Group type: EXPERIMENTAL
Intervention: Knowledge of EVD
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Risk of exposure to infection
Number of subjects: 510

Group type: EXPERIMENTAL
Intervention: Health-seeking behavior
Number of subjects: 510
Study: 32310676

Group type: EXPERIMENTAL
Intervention: Circular yellow indication (CY)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Following vehicle type (heavy vehicle vs passenger car)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Time to stop line
Number of subjects: 45
Study: 36364740

Group type: EXPERIMENTAL
Intervention: Fig leaf tea
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 35545414

Group type: EXPERIMENTAL
Intervention: Sticker group
Number of subjects: 67

Group type: COMPARATOR
Intervention: Marker pen group
Number of subjects: 67
Study: 32026435

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 35449097

Group type: EXPERIMENTAL
Intervention: Laser hemorrhoidoplasty (LHP) only
Number of subjects: 76

Group type: COMPARATOR
Intervention: Laser hemorrhoidoplasty with hemorrhoidal artery ligation (HAL)
Number of subjects: 76
Study: 34387431

Group type: EXPERIMENTAL
Intervention: Anterior subtotal vertebral body resection + titanium mesh reconstruction + screw rod internal fixation (Group A)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Posterior 270° ring decompression of vertebral canal + titanium mesh reconstruction + screw rod internal fixation (Group B)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 32
Study: 36111858

Group type: EXPERIMENTAL
Intervention: Nintedanib
Number of subjects: 576

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study: 33397459

Group type: EXPERIMENTAL
Intervention: Palate surgery at 6 months of age
Number of subjects: 0

Group type: COMPARATOR
Intervention: Palate surgery at 12 months of age
Number of subjects: 0
Study: 35679826

Group type: EXPERIMENTAL
Intervention: Dual-task Zumba Gold (DTZ)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Health education (Control)
Number of subjects: 60
Study: 35645079

Group type: EXPERIMENTAL
Intervention: Group A - light cure resin cement - Variolink N LC by Ivoclar Vivadent in clear shade
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group B - base paste of dual‐cure resin cement - Variolink N by Ivoclar Vivadent in transparent shade
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group C - dual‐cure resin cement - Clearfil esthetic cement EX by Kuraray in clear shade
Number of subjects: 60
Study: 32927895

Group type: EXPERIMENTAL
Intervention: Fast eating (10 min)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Slow eating (20 min)
Number of subjects: 19
Study: 33109913

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 861

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 861
Study: 33910487

Group type: EXPERIMENTAL
Intervention: CBT
Number of subjects: 254

Group type: COMPARATOR
Intervention: CBT enriched with emotion regulation training (ENCERT)
Number of subjects: 254
Study: 32301591

Group type: EXPERIMENTAL
Intervention: Pimavanserin 34 mg/day
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study: 35381839

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg orally two hours before surgery and 24 hours after surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33993136

Group type: EXPERIMENTAL
Intervention: Enhanced oral care (intervention units)
Number of subjects: 8709

Group type: COMPARATOR
Intervention: Usual oral care (control units)
Number of subjects: 8709
Study: 32804957

Group type: EXPERIMENTAL
Intervention: Dehydrated sewage sludge (DSS) application
Number of subjects: 24

Group type: COMPARATOR
Intervention: No dehydrated sewage sludge (DSS) application
Number of subjects: 24
Study: 35947288

Group type: EXPERIMENTAL
Intervention: Early intervention with bioimpedance spectroscopy (BIS) and a compression garment applied for 12 hours a day over 4 weeks
Number of subjects: 2907

Group type: COMPARATOR
Intervention: Tape measurement coupled with early intervention
Number of subjects: 2907
Study: 32325012

Group type: EXPERIMENTAL
Intervention: Oral antibiotics (ciprofloxacin 750 mg every 12 h and metronidazole 250 mg every 8 h the day before surgery)
Number of subjects: 565

Group type: COMPARATOR
Intervention: No oral antibiotics (control group)
Number of subjects: 565

Group type: EXPERIMENTAL
Intervention: Oral antibiotics (experimental group)
Number of subjects: 565
Study: 35103815

Group type: EXPERIMENTAL
Intervention: 3D printing technique (G1; n = 20)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional technique (G2; n = 23)
Number of subjects: 43
Study: 33719478

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 60
Study: 32400732

Group type: EXPERIMENTAL
Intervention: Traditional massage in addition to routine physical therapy (once daily, five times a week for three months)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Routine physical therapy (once daily, five times a week for three months)
Number of subjects: 86
Study: 35728048

Group type: EXPERIMENTAL
Intervention: Pevonedistat + azacitidine (n = 227)
Number of subjects: 554

Group type: COMPARATOR
Intervention: Azacitidine monotherapy (n = 227)
Number of subjects: 554
Study: 32947067

Group type: EXPERIMENTAL
Intervention: Post-PE rehabilitation intervention
Number of subjects: 26
Study: 35689281

Group type: EXPERIMENTAL
Intervention: Partnership in iSupport program
Number of subjects: 185

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 185
Study: 33574974

Group type: EXPERIMENTAL
Intervention: Lidocaine plus dexmedetomidine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lidocaine alone
Number of subjects: 40
Study: 32479807

Group type: EXPERIMENTAL
Intervention: Alcon model SN60WF
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Hoya model XY‐1
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: AMO model ZCB00V
Number of subjects: 195
Study: 36115850

Group type: EXPERIMENTAL
Intervention: MVC-COV1901
Number of subjects: 100

Group type: COMPARATOR
Intervention: ChAdOx1
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Heterologous schedule
Number of subjects: 100
Study: 33028132

Group type: EXPERIMENTAL
Intervention: High-dose melphalan with autologous stem cell transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bortezomib-based regimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ixazomib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carfilzomib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pomalidomide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daratumumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elotuzumab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isatuximab
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Venetoclax
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NEOD001
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Melflufen
Number of subjects: 0
Study: 36437902

Group type: EXPERIMENTAL
Intervention: Active group (real HF-rTMS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham group (sham HF-rTMS)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups (active and sham)
Number of subjects: 64
Study: 32902668

Group type: EXPERIMENTAL
Intervention: Submucosal dexamethasone (8 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intravenous dexamethasone (8 mg)
Number of subjects: 30
Study: 35641979

Group type: EXPERIMENTAL
Intervention: Shared Decision Making Assistant application
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 180
Study: 36413261

Group type: EXPERIMENTAL
Intervention: UP446
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 33515745

Group type: EXPERIMENTAL
Intervention: GoreTex (2-0 GoreTex)
Number of subjects: 200

Group type: COMPARATOR
Intervention: PDS (2-0 PDS)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both interventions (GoreTex and PDS)
Number of subjects: 200
Study: 33752252

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 32020470

Group type: EXPERIMENTAL
Intervention: TTFields/TMZ
Number of subjects: 39

Group type: COMPARATOR
Intervention: TMZ alone
Number of subjects: 39
Study: 36107667

Group type: EXPERIMENTAL
Intervention: Long COVID description
Number of subjects: 1110

Group type: EXPERIMENTAL
Intervention: Symptom uncertainty emphasized
Number of subjects: 1110

Group type: EXPERIMENTAL
Intervention: Enhanced support
Number of subjects: 1110

Group type: COMPARATOR
Intervention: Ongoing COVID-19 recovery description
Number of subjects: 1110

Group type: COMPARATOR
Intervention: Symptom uncertainty not emphasized
Number of subjects: 1110

Group type: COMPARATOR
Intervention: Basic support
Number of subjects: 1110
Study: 32994490

Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid (5-ALA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 36098362

Group type: EXPERIMENTAL
Intervention: Metformin plus Bifidobacterium animalis subsp. lactis (BB‐12) probiotic (MET-PRO group)
Number of subjects: 156

Group type: COMPARATOR
Intervention: Metformin alone (MET group)
Number of subjects: 156
Study: 35725247

Group type: EXPERIMENTAL
Intervention: Computer-based cognitive training at home (once a week in SLT office plus one or three times per week at home)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular condition (once a week in SLT office only)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Training frequency (once a week in SLT office plus one or three times per week at home)
Number of subjects: 0
Study: 33811308

Group type: EXPERIMENTAL
Intervention: Sulpiride (200 mg)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 32972311

Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation intervention
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Therapeutic relationship
Number of subjects: 51
Study: 34328440

Group type: EXPERIMENTAL
Intervention: Feedback group (mHealth tool with real-time quality feedback)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Basic group (mHealth tool without real-time quality feedback)
Number of subjects: 21
Study: 32605239

Group type: EXPERIMENTAL
Intervention: U-shaped automatic electric toothbrush (U)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional powered toothbrush (P)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Habitual toothbrushing procedure (H)
Number of subjects: 22

Group type: COMPARATOR
Intervention: No brushing (N)
Number of subjects: 22
Study: 36181480

Group type: EXPERIMENTAL
Intervention: 100-mg testosterone cypionate (weekly intramuscular injections)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Placebo (weekly intramuscular injections)
Number of subjects: 142
Study: 34452930

Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg every 2 weeks
Number of subjects: 905

Group type: COMPARATOR
Intervention: Ipilimumab 10 mg/kg every 3 weeks for four doses and then every 12 weeks
Number of subjects: 905
Study: 33645312

Group type: EXPERIMENTAL
Intervention: Text processing + foundational skills (n = 117)
Number of subjects: 364

Group type: EXPERIMENTAL
Intervention: Text processing only (n = 120)
Number of subjects: 364

Group type: COMPARATOR
Intervention: Control condition (n = 127)
Number of subjects: 364
Study: 34176722

Group type: EXPERIMENTAL
Intervention: CNSA-001 (sepiapterin, PTC923) 10 mg/kg BID for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32590251

Group type: EXPERIMENTAL
Intervention: Peripheral nerve radiofrequency thermocoagulation (PRF) via the foramen rotundum and foramen ovale
Number of subjects: 102

Group type: COMPARATOR
Intervention: Semilunar ganglion radiofrequency thermocoagulation (GRF)
Number of subjects: 102
Study: 33293114

Group type: EXPERIMENTAL
Intervention: Facial threading (3 sessions every 21 days)
Number of subjects: 18
Study: 35278283

Group type: EXPERIMENTAL
Intervention: Dupilumab 200 mg administered via autoinjector (AI)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Dupilumab 200 mg administered via prefilled syringe with needle shield (PFS-S)
Number of subjects: 130
Study: 34507265

Group type: EXPERIMENTAL
Intervention: BMI (Body Mass Index)
Number of subjects: 339224
Study: 34370330

Group type: EXPERIMENTAL
Intervention: Movement pattern training (MoveTrain)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard strength and flexibility training (Standard)
Number of subjects: 27
Study: 33310803

Group type: EXPERIMENTAL
Intervention: Rotator Cuff Unloading Exercise Programme
Number of subjects: 78

Group type: COMPARATOR
Intervention: Rotator Cuff Loading Exercise Programme
Number of subjects: 78
Study: 35310181

Group type: EXPERIMENTAL
Intervention: DVT general prevention + basic physical prevention + NMES
Number of subjects: 278

Group type: COMPARATOR
Intervention: DVT general prevention + basic physical prevention
Number of subjects: 278
Study: 37605078

Group type: EXPERIMENTAL
Intervention: Percutaneous endoscopic transforaminal discectomy (PETD)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Percutaneous endoscopic interlaminar discectomy (PEID)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 113
Study: 32553428

Group type: EXPERIMENTAL
Intervention: 10 mg enalapril and 0.8 mg folic acid
Number of subjects: 10699

Group type: COMPARATOR
Intervention: 10 mg enalapril alone
Number of subjects: 10699
Study: 32054896

Group type: EXPERIMENTAL
Intervention: Instability resistance training
Number of subjects: 68

Group type: COMPARATOR
Intervention: Stable machine-based resistance training
Number of subjects: 68
Study: 34024505

Group type: EXPERIMENTAL
Intervention: Intervention menu with culinary improvements (popular meals-on-wheels, main meal for dinner, starter/dessert)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Intervention menu with culinary improvements
Number of subjects: 52

Group type: COMPARATOR
Intervention: Non-optimized menu (control group)
Number of subjects: 52
Study: 36462699

Group type: EXPERIMENTAL
Intervention: Comprehensive methodology for evaluating CRS performance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Targeted messaging relating to performance metrics
Number of subjects: 0
Study: 32602744

Group type: EXPERIMENTAL
Intervention: Therapeutic Meibomian gland expression
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 44
Study: 33291649

Group type: EXPERIMENTAL
Intervention: 0.6 L/day of an artificially sweetened soft drink containing acesulfame K (950) and aspartame (951) for 2 weeks
Number of subjects: 39

Group type: COMPARATOR
Intervention: 0.6 L/day of mineral water for 2 weeks
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring during each 2 week period
Number of subjects: 39
Study: 33671093

Group type: EXPERIMENTAL
Intervention: LEA with low protein (LEA-LP; 0.8 g protein·kg BW-1)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: LEA with high protein (LEA-HP; 1.7 g protein·kg BW-1)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (CON; 40 kcal·kg FFM-1·day-1, 1.7 g protein·kg BW-1)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: LEA (both LEA-LP and LEA-HP)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: LEA-LP vs LEA-HP
Number of subjects: 7
Study: 33087055

Group type: EXPERIMENTAL
Intervention: Selenium (L‐selenomethionine) 200 μg/day for 3 months
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (nothing, in addition to recommended therapy)
Number of subjects: 100
Study: 32100501

Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) combined with penetrating moxibustion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Biofeedback electrical stimulation
Number of subjects: 60
Study: 35665800

Group type: EXPERIMENTAL
Intervention: Precision prevention materials incorporating melanocortin‐1 receptor genetic risk information
Number of subjects: 1134

Group type: COMPARATOR
Intervention: Generic prevention materials
Number of subjects: 1134
Study: 33283579

Group type: EXPERIMENTAL
Intervention: CCTA
Number of subjects: 1050

Group type: COMPARATOR
Intervention: SPECT
Number of subjects: 1050
Study: 35450203

Group type: EXPERIMENTAL
Intervention: SGB combined with 0.25% lidocaine (Group A)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: SGB combined with 0.5% lidocaine (Group B)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: SGB combined with 0.75% lidocaine (Group C)
Number of subjects: 90
Study: 34293081

Group type: COMPARATOR
Intervention: Low-SAA group (n=20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-SAA group (n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cold rice
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Hot rice
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: High-SAA group (n=19)
Number of subjects: 40
Study: 32516300

Group type: EXPERIMENTAL
Intervention: Training to target step length asymmetry
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Training to target stance time asymmetry
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Step length asymmetry improvements
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Stance time asymmetry improvements
Number of subjects: 48
Study: 33407195

Group type: EXPERIMENTAL
Intervention: Stepped counselling approach for burdened caregivers delivered by care counsellors and registered psychotherapists
Number of subjects: 572

Group type: COMPARATOR
Intervention: Routine care and counselling (control group)
Number of subjects: 572
Study: 32424169

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (30 mins running, 4 days per week for 3 months)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Psychoeducation control group
Number of subjects: 39
Study: 35418214

Group type: EXPERIMENTAL
Intervention: Blended learning programme with face-to-face training and an online module on handover practice (n=50)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Waitlist control group receiving only face-to-face handover training (n=46)
Number of subjects: 96
Study: 33872587

Group type: EXPERIMENTAL
Intervention: Mepolizumab 100 mg subcutaneously once every 4 weeks for 52 weeks
Number of subjects: 414

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 414
Study: 32771061

Group type: EXPERIMENTAL
Intervention: EMDR (Eye Movement Desensitization and Reprocessing)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study: 35803707

Group type: EXPERIMENTAL
Intervention: Neutropenic diet
Number of subjects: 200

Group type: COMPARATOR
Intervention: Regular diet
Number of subjects: 200